Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage

被引:36
作者
Fernandez-Cruz, Laureano [1 ]
Jimenez Chavarria, Enrique [1 ]
Taura, Pilar [2 ]
Closa, Daniel [3 ]
Lopez Boado, Miguel-Angel [1 ]
Ferrer, Joana [1 ]
机构
[1] Hosp Clin Barcelona, Clin Inst Digest & Metab Dis, Inst Clin Malalties Digest & Metab, Dept Surg, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Clin Inst Digest & Metab Dis, Inst Clin Malalties Digest & Metab, Dept Anaesthesiol, E-08036 Barcelona, Spain
[3] Hosp Clin Barcelona, Clin Inst Digest & Metab Dis, Inst Clin Malalties Digest & Metab, Dept Expt Pathol IIBB CSIC, E-08036 Barcelona, Spain
关键词
POSTOPERATIVE COMPLICATIONS; PROPHYLACTIC OCTREOTIDE; CONTROLLED MULTICENTER; EXOCRINE FUNCTION; PREVENTION; SOMATOSTATIN; FISTULA; RISK; SURGERY; MANAGEMENT;
D O I
10.1111/j.1477-2574.2012.00608.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Octreotide is generally administered based on the surgeon's interpretation of perceived risk for pancreatic fistula at the time of pancreaticoduodenectomy (PD). Methods A single-institution, prospective randomized trial was conducted between April 2009 and December 2011 involving 62 PD patients who were randomized to receive octreotide (100g subcutaneously every 8h; n = 32) or placebo (n = 30). Pancreatic juice output was measured after the operation using a catheter inserted into the pancreatic duct. Postoperative complications were recorded. Results No significant differences in median output were found between the octreotide (82.5ml) and placebo (77.5ml) groups (P = 0.538). Median total output was significantly lower in patients with adenocarcinoma compared with those with periampullary tumours (P = 0.004) and in patients with a duct diameter of >5mm compared with those with a duct diameter of <5mm (P = 0.001). There were no significant differences in overall morbidity between the octreotide and placebo groups (P = 0.819). Grade B pancreatic fistula (International Study Group for Pancreatic Fistula) was observed in two and three patients in the octreotide and placebo groups, respectively. Conclusions Morbidity did not differ significantly between the groups. This study did not demonstrate an inhibitory effect of octreotide on exocrine pancreatic secretion. Based on these results, the routine use of octreotide after PD cannot be recommended.
引用
收藏
页码:392 / 399
页数:8
相关论文
共 47 条
[1]  
Alghamdi AA, 2007, CAN J SURG, V50, P459
[2]   Ten-year experience with 733 pancreatic resections - Changing indications, older patients, and decreasing length of hospitalization [J].
Balcom, JH ;
Rattner, DW ;
Warshaw, AL ;
Chang, Y ;
Fernandez-del Castillo, C .
ARCHIVES OF SURGERY, 2001, 136 (04) :391-397
[3]  
Barnett SP, 2004, AM SURGEON, V70, P222
[4]   Postoperative pancreatic fistula: An international study group (ISGPF) definition [J].
Bassi, C ;
Dervenis, C ;
Butturini, G ;
Fingerhut, A ;
Yeo, C ;
Izbicki, J ;
Neoptolemos, J ;
Sarr, M ;
Traverso, W ;
Buchler, M .
SURGERY, 2005, 138 (01) :8-13
[5]   Does Type of Pancreaticojejunostomy after Pancreaticoduodenectomy Decrease Rate of Pancreatic Fistula? A Randomized, Prospective, Dual-institution Trial [J].
Berger, Adam C. ;
Howard, Thomas J. ;
Kennedy, Eugene P. ;
Sauter, Patricia K. ;
Bower-Cherry, Maryanne ;
Dutkevitch, Sarah ;
Hyslop, Terry ;
Schmidt, C. Max ;
Rosato, Ernest L. ;
Lavu, Harish ;
Nakeeb, Atilla ;
Pitt, Henry A. ;
Lillemoe, Keith D. ;
Yeo, Charles J. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (05) :738-747
[6]   ROLE OF OCTREOTIDE IN THE PREVENTION OF POSTOPERATIVE COMPLICATIONS FOLLOWING PANCREATIC RESECTION [J].
BUCHLER, M ;
FRIESS, H ;
KLEMPA, I ;
HERMANEK, P ;
SULKOWSKI, U ;
BECKER, H ;
SCHAFMAYER, A ;
BACA, I ;
LORENZ, D ;
MEISTER, R ;
KREMER, B ;
WAGNER, P ;
WITTE, J ;
ZURMAYER, EL ;
SAEGER, HD ;
RIECK, B ;
DOLLINGER, P ;
GLASER, K ;
TEICHMANN, R ;
KONRADT, J ;
GAUS, W ;
DENNLER, HJ ;
WELZEL, D ;
BEGER, HG .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (01) :125-131
[7]   Prevention and Management of Pancreatic Fistula [J].
Callery, Mark P. ;
Pratt, Wande B. ;
Vollmer, Charles M., Jr. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 13 (01) :163-173
[8]  
Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea
[9]   Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery [J].
Connor, S ;
Alexakis, N ;
Garden, OJ ;
Leandros, E ;
Bramis, J ;
Wigmore, SJ .
BRITISH JOURNAL OF SURGERY, 2005, 92 (09) :1059-1067
[10]   Pancreaticojejunostomy versus pancreaticogastrostomy [J].
Fernandez-Cruz, Laureano .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2011, 18 (06) :762-768